StockData
ENvue Medical, Inc. logo

ENvue Medical, Inc. (FEED) stock

FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 5/30
$0.50+0.13 (+34.73%)

Close on Oct 19, 2026Market cap $3.08MP/E –Yield –

ENvue Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

ENvue Medical's operating income for the twelve months ending Jun 30, 2026 was -$26.25M. For fiscal 2025 it was -$22.89M. The highest annual figure on record is -$1.21M in fiscal 2014.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.89M–
FY2024Dec 31, 2024-$3.58M–
FY2023Dec 31, 2023-$3.44M–
FY2022Dec 31, 2022-$5.01M–
FY2021Dec 31, 2021-$5.68M–
FY2020Dec 31, 2020-$4.72M–
FY2019Dec 31, 2019-$5.15M–
FY2018Dec 31, 2018-$4.30M–
FY2017Dec 31, 2017-$3.09M–
FY2016Dec 31, 2016-$2.32M–
FY2015Dec 31, 2015-$1.42M–
FY2014Dec 31, 2014-$1.21M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.47M–
Q1 FY2026Mar 31, 2026-$3.71M–
Q4 FY2025Dec 31, 2025-$14.81M–
Q3 FY2025Sep 30, 2025-$2.25M–
Q2 FY2025Jun 30, 2025-$3.98M–
Q1 FY2025Mar 31, 2025-$1.85M–
Q4 FY2024Dec 31, 2024-$1.37M–
Q3 FY2024Sep 30, 2024-$970.00K–
Q2 FY2024Jun 30, 2024-$674.00K–
Q1 FY2024Mar 31, 2024-$568.00K–
Q4 FY2023Dec 31, 2023-$702.00K–
Q3 FY2023Sep 30, 2023-$670.00K–
Q2 FY2023Jun 30, 2023-$1.01M–
Q1 FY2023Mar 31, 2023-$1.06M–
Q4 FY2022Dec 31, 2022-$1.71M–
Q3 FY2022Sep 30, 2022-$924.00K–
Q2 FY2022Jun 30, 2022-$1.27M–
Q1 FY2022Mar 31, 2022-$1.11M–
Q4 FY2021Dec 31, 2021-$2.51M–
Q3 FY2021Sep 30, 2021-$868.00K–
Q2 FY2021Jun 30, 2021-$991.00K–
Q1 FY2021Mar 31, 2021-$1.31M–
Q4 FY2020Dec 31, 2020-$1.54M–
Q3 FY2020Sep 30, 2020-$804.00K–
Q2 FY2020Jun 30, 2020-$1.47M–
Q1 FY2020Mar 31, 2020-$907.00K–
Q4 FY2019Dec 31, 2019-$1.24M–
Q3 FY2019Sep 30, 2019-$793.00K–
Q2 FY2019Jun 30, 2019-$896.00K–
Q1 FY2019Mar 31, 2019-$2.22M–
Q4 FY2018Dec 31, 2018-$1.36M–
Q3 FY2018Sep 30, 2018-$1.33M–
Q2 FY2018Jun 30, 2018-$825.00K–
Q1 FY2018Mar 31, 2018-$790.00K–
Q4 FY2017Dec 31, 2017-$1.02M–
Q3 FY2017Sep 30, 2017-$613.00K–
Q2 FY2017Jun 30, 2017-$660.00K–
Q1 FY2017Mar 31, 2017-$802.00K–
Q2 FY2016Jun 30, 2016-$456.00K–

More ENvue Medical figures

See a number that looks wrong?